EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive
At Group level, sales of EUR 730.1 million were achieved, an increase of 3.6% compared to 2022.
- At Group level, sales of EUR 730.1 million were achieved, an increase of 3.6% compared to 2022.
- At EUR 12.7 million, the Group operating result was EUR 6.8 million below the previous year's figure (2022: EUR 19.5 million) due to a one-off effect.
- Sales include services from the protective shield totalling EUR 7.4 million, which is less than in 2022 (EUR 11.7 million).
- Sales in the acute segment totalled EUR 254.0 million, an increase of EUR 1.3 million or 0.5% compared to the previous year.